First marketing approval granted for Vitrase in Mexico; U.S. phase III trials now under way Nov. 24, 1998 No Comments
Latanoprost monotherapy is as effective as combination therapy in lowering IOP Nov. 20, 1998 No Comments
New prostaglandins with IOP-lowering effects disclosed by Santen and Asahi Glass Nov. 16, 1998 No Comments
Significant antiinflammatory activity seen with loteprednol etabonate in cataract surgery setting Nov. 5, 1998 No Comments
RSS